A detailed history of Cromwell Holdings LLC transactions in Argenx Se stock. As of the latest transaction made, Cromwell Holdings LLC holds 156 shares of ARGX stock, worth $93,498. This represents 0.06% of its overall portfolio holdings.

Number of Shares
156
Previous 90 73.33%
Holding current value
$93,498
Previous $38,000 121.05%
% of portfolio
0.06%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$434.22 - $551.9 $28,658 - $36,425
66 Added 73.33%
156 $84,000
Q2 2024

Aug 14, 2024

BUY
$356.01 - $451.55 $32,040 - $40,639
90 New
90 $38,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $33.2B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Cromwell Holdings LLC Portfolio

Follow Cromwell Holdings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cromwell Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cromwell Holdings LLC with notifications on news.